Prevention of Ovarian High-Grade Serious Carcinoma by Elucidating its Early Changes DoD-CDMRP Consortium Grant Award, 2011-2018
Administrative Director: Tian-Li Wang, PhD
Administrative Co-Director: Ie-Ming Shih, MD, PhD
Emeritus Director: Robert J Kurman, MD
The Consortium we have established in 2011 consists of four Research Sites including Johns Hopkins (JHU), Yale University (YU), Memorial Sloan Kettering Cancer Center (MSKCC) and University of Toronto Health Network (THUN), with JHU serving as the coordinator center . DoD-CDMRP initially funded the preparation phase of this consortium, which subsequently received a multi-million dollars grant from year 2011-2018. The Consortium is a coordinated, collaborative, interdisciplinary program that brings together a group of highly experienced investigators who have devoted their careers to translational research in ovarian cancer featuring pathology, gynecology, oncology, epidemiology, and molecular genetics. The studies in this Consortium are highly coordinated and interrelated and are centered around one theme, namely the elucidation of the early events of ovarian HGSC. Moreover, various technologies that will be used by different projects will be centralized in the different Research Sites so as to avoid duplication of effort.
Administrative Core
Ie-Ming Shih, MD, PhD (Johns Hopkins University)
Tian-Li Wang, PhD (Johns Hopkins University)
Pathology Core
Robert Soslow, MD (Memorial Sloan Kettering Cancer Center)
Russell Vang, MD (Johns Hopkins University)
Vinita Parkash, MBBS (Yale University)
Biostatistics/Epidemiology Core
Gary Rosner, ScD (Johns Hopkins University)
Kala Visvanathan, MD (Johns Hopkins University)
Leslie Cope, PhD (Johns Hopkins University)
